ROS1-rearranged high-PD-L1-expressing lung adenocarcinoma manifesting as mediastinal tumor: A case report

ROS proto-oncogene 1 receptor tyrosine kinase (ROS1)-rearranged lung cancer is rare and comprises only 1% of lung adenocarcinoma cases. It has recently been reported to have good response to crizotinib, a tyrosine kinase inhibitor of anaplastic lymphoma kinase. Driver oncogene mutations with approve...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncol Lett
Main Authors: Ogawa, Hiroyuki, Tanaka, Yugo, Tachihara, Motoko, Uehara, Keiichiro, Shimizu, Nahoko, Doi, Takefumi, Hokka, Daisuke, Maniwa, Yoshimasa
格式: Artigo
語言:Inglês
出版: D.A. Spandidos 2019
主題:
Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6313173/
https://ncbi.nlm.nih.gov/pubmed/30655791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9622
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍